DoctorsProofNPPES directory · verify at state boards

Pulmonary Disease in Gadsden, AL

5 verified pulmonary disease doctors in Gadsden.

Pulmonologists diagnose and treat diseases of the lungs and respiratory system, such as asthma, COPD, and sleep apnea.

NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.

Verify a license at the Alabama Board of Medical Examiners

Dr. Muhammad Kaleem, MD

Pulmonary Disease

20 yrs NPPES
NPI 1285697078
300 MEDICAL CENTER DR, SUITE 200, Gadsden, AL 35903(256) 494-4646
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $356.18 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$356.18

Total received

19

Transactions

11

Paying companies

Top paying companies

GlaxoSmithKline, LLC.$56.85
Mylan Specialty L.P.$42.69
Insmed, Inc.$38.44
Intuitive Surgical, Inc.$38.00
AstraZeneca Pharmaceuticals LP$36.18
Philips North America LLC$31.61

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 70th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Muhammad Kaleem do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Mazen Hakim, MD

Pulmonary Disease

20 yrs NPPES
NPI 1114016920
1026 GOODYEAR AVE, SUITE 302, Gadsden, AL 35903(256) 543-3877
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $179.64 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$179.64

Total received

11

Transactions

6

Paying companies

Top paying companies

GlaxoSmithKline, LLC.$47.79
Philips North America LLC$42.86
Axsome Therapeutics, Inc.$35.76
Genzyme Corporation$22.89
Insmed, Inc.$16.36
Actelion Pharmaceuticals US, Inc.$13.98

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 64th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Mazen Hakim do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Sikander Zulqarnain, MD

Pulmonary Disease

16 yrs NPPES
NPI 1366751257
303 BAY ST STE 100, Gadsden, AL 35901(256) 413-6520
NPPES public registry
CMS Open Payments· $34.67 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$34.67

Total received

1

Transactions

1

Paying companies

Top paying companies

Abbott Laboratories$34.67

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 52th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Sikander Zulqarnain do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Kerri Bally, MD

Pulmonary Disease

11 yrs NPPES
NPI 1245606805
300 MEDICAL CENTER DR # 300, Gadsden, AL 35903(256) 494-4646
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $397.16 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$397.16

Total received

23

Transactions

6

Paying companies

Top paying companies

AstraZeneca Pharmaceuticals LP$128.16
GlaxoSmithKline, LLC.$127.99
Mylan Specialty L.P.$56.54
Insmed, Inc.$38.43
Amgen Inc.$29.55
Paratek Pharmaceuticals, Inc.$16.49

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 71th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Kerri Bally do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Ali Al-Tarbsheh, MD

Pulmonary Disease

7 yrs NPPES
NPI 1659932341
1026 GOODYEAR AVE STE 302B, Gadsden, AL 35903(256) 485-0899
NPPES public registry
CMS Open Payments· $593.03 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$593.03

Total received

8

Transactions

5

Paying companies

Top paying companies

AstraZeneca Pharmaceuticals LP$244.19
GlaxoSmithKline, LLC.$124.99
Amgen Inc.$122.66
Boehringer Ingelheim Pharmaceuticals, Inc.$74.95
Genzyme Corporation$26.24

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 75th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Ali Al-Tarbsheh do not imply any wrongdoing. Many are meals, education, or research support.

Pulmonary Disease in Gadsden, AL — Verified | DoctorsProof | DoctorsProof